The association between glutathione S-transferase T1 and M1 gene polymorphisms and microalbuminuria and incipient nephropathy in children with type 1 diabetes mellitus
Authors:
J. Vojtková; M. Čiljaková; P. Ďurdík; Z. Michnová; T. Turčan
Authors‘ workplace:
Klinika detí a dorastu, Univerzita Komenského v Bratislave, Jesseniova lekárska fakulta a Univerzitná nemocnica Martin
prednosta prof. MUDr. P. Bánovčin, CSc.
Published in:
Čes-slov Pediat 2013; 68 (2): 92-100.
Category:
Original Papers
Overview
Oxidative stress is discussed factor in the etiopathogenesis of diabetic nephropathy (DN). Glutathione S-transferase (GST) represents the family of multifunctional isoenzymes with antioxidant function. The most researched isoenzymes are glutathione S-transferase theta 1 (GST T1) and mu 1 (GST M1) while null polymorphisms are associated with lower activity of these enzymes. The aim of this work was to establish, whether GST T1 and M1 gene polymorphisms were linked to presence of microalbuminuria and diabetic nephropathy in children with type 1 diabetes.
In 116 patients with type 1 diabetes at the age 6–19 years, basic anthropometric parameters were noticed, glycosylated hemoglobin was examined by standard biochemical methods and microalbuminuria was examined from 12-hour night urine sample. Incipient nephropathy was diagnosed as repeated finding of microalbuminuria of 20–200 μg/min. GST T1 and M1 gene polymorphisms were established by polymerase chain reaction.
Children with GST T1 null genotype (n=42) had significantly higher microalbuminuria compared to the subjects with GST T1 wild genotype (n=74) (p<0.05). No significant difference was found in other measured parameters. Similarly, no significant difference was estimated in measured parameters between subjects regarding GST M1 genotype. Incipient nephropathy was diagnosed in 26 children (22.41%). Patients with diabetic nephropathy (DN+) had significantly higher age (p<0.01), longer diabetes duration (p<0.01), higher body mass index (p<0.01) and higher microalbuminuria (p<0.01) compared to patients without nephropathy (DN-). These parameters were confirmed as risk factors for DN origin by multivariate logistic regression. Differences in gene polymorphisms between DN+ and DN- subgroups were not significant.
GST T1 null genotype may be associated with higher microalbuminuria, however further studies are necessary to confirm this indication.
Key words:
diabetic nephropathy, gene polymorphisms, glutathione S-transferase T1 and M1
Sources
1. Rybka J. Diabetes mellitus – komplikace a přidružená onemocnění. 1. vyd. Praha: Grada, 2007: 1–320.
2. Bouček P, Kvapil M, Monhart V, Pelikanova T, Rychlik I, a spol. Česká diabetologická společnost ČLS JEP a Česká nefrologická společnost. Doporučené postupy při diabetickém onemocnění ledvin. Aktuality v nefrologii 2012; 18: 18–26.
3. Ha H, Hwang IA, Park JH, Lee HB. Role of rective oxygen species in the pathogenesis of diabetic nephropathy. Diabetes Res Clin Pract 2008; 82: S42–45.
4. Chudý P, Bánovčin P ml. Poruchy hemostázy pri nešpecifických črevných zápaloch. Lekársky obzor 2008; 56 (7–8): 324–329.
5. Oliviera AL, Rodrigues FF, Santos RE, Aoki T, Rocha MN, et al. GSTT1, GSTM1 and GSTP1 polymorphisms and chemotherapy response in locally advanced breast cancer. Genet Mol Res 2010; 9: 1045–1053.
6. Datta SK, Kumar V, Ahmed RS, Tripathi AK, Kalra OP, Banerjee BD. Effect of GSTM1 and GSTT1 double deletions in the development of oxidative stress in diabetic nephropathy patients. Indian J Biochem Biophys 2010; 47: 100–103.
7. Bid HK, Konwar R, Saxena M, Chaudhari P, Agrawal CG, Banerjee M. Association of glutathione S-transferase (GSTM1, T1 and P1) gene polymorphisms with type 2 dia-betes mellitus in north Indian population. J Postgrad Med 2010; 56: 176–181.
8. Ramprasath T, Senthil Murugan P, Prabakaran AD, Gomathi P, Rathinavel A, Selvam GS. Potential risk modifications of GSTT1, GSTM1 and GSTP1 (glutathione-S-transferases) variants and their association to CAD in patients with type-2 diabetes. Biochem Biophys Res Commun 2011; 407: 49–53.
9. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008; 31: S55–S60.
10. Havlicekova Z, Jurko A Jr. Heart rate variability changes in children after cardiac transplantation. Bratisl lek Listy 2005; 106: 168–170.
11. Brndiarová M, Mikler J, Bánovčin P., Michnová T, Fábry J. Extraezofágový reflux – otorinolaryngologické komplikácie gastroezofágového refluxu. Čes-slov Pediat 2011; 66: 85–91.
12. Babušíková E, Jeseňák M, Kirschnerová R, Bánovčin P, Dobrota D. Association of oxidative stress and GST-T1 gene with childhood bronchial asthma. J Phy-siol Pharmacol 2009; 60: S27–30.
13. Jeseňák M, Havlíčeková Z, Buchanec J, Villa MP, Ronchetti R, Bánovčin P. Diagnostický algoritmus potravinovej alergie v detskom veku. Čes-slov Pediat 2008; 63: 272–282.
14. Mikler J, Banovcin P, Jesenak M, Hamzikova J, Statelova D. Successful treatment of extreme acute lead intoxication. Toxicol Ind Health 2009; 25: 137–140.
15. Sivák S, Kurca E, Hladká M, Zelenák K, Turcanová-Koprusáková M, Michalik J. Early and delayed auditory oddball ERPs and brain MRI in patients with MTBI. Brain Inj 2008 Feb; 22 (2):193–197.
16. Straka L, Novomeský F, Krajcovic J, Stuller F, Brzo-bohatá A, Vojtísek T. Forensic interpretation of postmortal ethanol neogenesis in blood samples of cadaverously decomposed bodies. Soud Lek 2010; 55 (2): 18–21.
17. Manfredi S, Calvi D, Fiandra M, Botto N, Biagini A, Andreassi MG. Glutathione S-transferase T1- and M1- null genotypes and coronary artery disease risk in patients with Type 2 diabetes mellitus. Pharmacogenomics 2009; 10: 29–34.
18. Yalin S, Hatungil R, Tamer L, Ates NA, Dogruer N, et al. Glutathine S-transferase gene polymorphisms in Turkish patients with diabetes mellitus. Cell Biochem Funct 2007; 25: 509–513.
19. Hori M, Oniki K, Ueda K, Goto S, Mihara S, et al. Combined glutathione-S-transpherase T1 and M1 positive genotype afford protection against type 2 diabetes in Japanese. Pharmacogenomics 2007; 8: 1307–1314.
20. Hossaini AM, Zamrroni IM, Kashem RA, Khan ZF. Polymorphism of glutathione S-transferases as genetic risk factors for the development of complica-tions in type 2 diabetes mellitus. J Crit Care 2008; 23: 444–448.
21. Bekris LM, Stephard C, Peterson M, Hoehna J, Van Yserloo B, et al. Glutathione-s-transpherase M1 and T1 polymorphisms and association with type 1 diabetes age-at-onset. Autoimmunity 2005; 38: 567–575.
22. Datta SK, Kumar V, Pathak R, Tripathi AK, Ahmed RS, et al. Association of glutathione S-transferase M1 and T1 gene polymorphism with oxidative stress in diabetic and nondiabetic chronic kidney disease. Ren Fail 2010; 32: 1189–1195.
23. Fujita H, Narita T, Meguro H, Shimotomai T, Kitazato H, et al. No association of glutathione S-transferase M1 gene polymorphism with diabetic nephropathy in Japanese type 2 diabetic patients. Ren Fail 2000; 22: 479–486.
24. Yang Y, Kao MT, Chang CC, Chung SY, Chen CM, et al. Glutathione S-transferase T1 deletion is a risk factor for developing end-stage renal disease in diabetic patients. Int J Mol Med 2004; 14: 855–859.
25. Hovnik T, Dolzan V, Bratina NU, Podkrajsek KT, Battelino T. Genetic polymorphisms in genes encoding antioxidant enzymes are associated with diabetic retinopathy in type 1 diabetes. Diabetes Care 2009; 32: 2258–2262.
26. Panduru NM, Moţa E, Moţa M, Cimponeriu D, Serafinceanu C, Cheţa DM. Polymorphism of catalase gene promoter in Romanian patients with diabetic kidney disease and type 1 diabetes. Rom J Intern Med 2010; 48: 81–88.
27. Dos Santos KG, Canani LH, Gross JL, Tschiedel B, Souto KE, Roisenberg I. The catalase -262C/T promoter polymorphism and diabetic complications in Caucasians with type 2 diabetes. Dis Markers 2006; 22: 355–359.
28. Mohammedi K, Maimaitiming S, Emery N, Bellili-Muñoz N, Roussel R, et al. Allelic variations in superoxide dismutase-1 (SOD1) gene are associated with increased risk of diabetic nephropathy in type 1 diabetic subjects. Mol Genet Metab 2011; 104: 654–660.
29. Lee SJ, Choi MG, Kim DS, Kim TW. Manganese superoxide dismutase gene polymorphism (V16A) is associated with stages of albuminuria in Korean type 2 diabetic patients. Metabolism 2006; 55: 1–7.
30. Viswanathan V, Tilak P, Kumpatla S. Risk factors associated with the development of overt nephropathy in type 2 diabetes patients: A 12 years observational study. Indian J Med Res 2012; 136: 46–53.
31. Zhou Y, Guo LX, Yu DN, Zhou L, Wang Y, et al. Analyses on the relative factors regarding diabetic nephropathy among 1758 cases of type 2 diabetic patients. Zhonghua Liu Xing Bing Xue Za Zhi 2012; 33: 610–613.
32. Suláková T, Janda J. Ambulatory blood pressure in children with diabetes 1. Pediatr Nephrol 2008; 23: 2285–2286.
33. Suláková T, Janda J, Cerná J, Janstová V, Suláková A, Slaný J, Feber J. Arterial HTN in children with T1DM-frequent and not easy to diagnose. Pediatric Diabetes 2009; 10: 441–448.
34. Bessa SS, Ali EM, Hamdy SM. The role of glutathione S- transferase M1 and T1 gene polymorphisms and oxidative stress-related parameters in Egyptian patients with essential hypertension.Eur J Intern Med 2009; 20: 625–630.
35. Capoluongo E, Onder G, Concolino P, Russo A, Santonocito C, et al. GSTM1-null polymorphism as possible risk marker for hypertension: results from the aging and longevity study in the Sirente Geographic Area (ilSIRENTE study). Clin Chim Acta 2009; 399: 92–96.
36. Chaturvedi N, Bandinelli S, Mangili R, Penno G, Rottiers RE, Fuller JH. Microalbuminuria in type 1 diabetes: rates, risk factors and glycemic threshold. Kidney Int 2001; 60: 219–227.
37. Stephenson JM, Fuller JH. Microalbuminuria is not rare before 5 years of IDDM: EURODIAB IDDM Complications Study Group and the WHO Multinational Study of Vascular Disease in Diabetes Study Group. J Diabetes Complications 1994; 8:166–173.
38. Donaghue KC, Chiarelli F, Trotta D, Allgrove J, Dahl-Jorgensen K. Microvascular and macrovascular complications associated with diabetes in children and adolescents. ISPAD Clinical Practice Consensus Guidelines 2009 Compendium. Pediatric Diabetes 2009; 10: 195–203.
39. Court JM, Cameron FJ, Berg-Kelly K, Swift PGF. Diabetes in adolescence. Pediatric Diabetes 2008; 9: 255–262.
Labels
Neonatology Paediatrics General practitioner for children and adolescentsArticle was published in
Czech-Slovak Pediatrics
2013 Issue 2
Most read in this issue
- Development of gut microbiota and risks of probiotics use in immunocompromised children
- A girl with karyotype 46, XY – case report
- Deficit of GATA-2 transcription factor: new immunodeficiency syndrome with broad phenotype. First patients diagnosed in the Czech Republic and review of the literature
- A survey of patients diagnosed with X-linked lymphoproliferation disease (XLP) in the Czech Republic and Slovakia